• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Top Ships Shares Are Trading Lower By Over 60%; Here Are 24 Stocks Moving Premarket

    12/5/22 8:16:29 AM ET
    $BABA
    $BILI
    $CLVS
    $COSM
    Real Estate
    Real Estate
    EDP Services
    Technology
    Get the next $BABA alert in real time by email

    Gainers

    • Cosmos Holdings Inc. (NASDAQ:COSM) shares rose 18.1% to $0.6316 in pre-market trading after jumping over 34% on Friday. Cosmos Holdings, last month, posted Q3 loss of $0.08 per share.
    • Zhihu Inc. (NYSE:ZH) shares rose 19.8% to $1.63 in pre-market trading after jumping 33% on Friday. Zhihu, last week, reported better-than-expected Q3 results.
    • Edgio, Inc. (NASDAQ:EGIO) rose 17% to $1.79 in pre-market trading. Edgio, last month, reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates.
    • 111, Inc. (NASDAQ:YI) rose 16.3% to $3.35 in pre-market trading. The company, last week, posted a narrower quarterly loss.
    • Tuniu Corporation (NASDAQ:TOUR) rose 15.3% to $1.43 in pre-market trading after jumping over 15% on Friday. Tuniu, last week, posted a Q3 loss of $0.03 per share.
    • Bilibili Inc. (NASDAQ:BILI) shares rose 14.9% to $22.80 in pre-market trading after jumping over 16% on Friday. Bilibili, last week, reported better-than-expected Q3 adjusted EPS and sales results.
    • XPeng Inc. (NYSE:XPEV) rose 13.3% to $12.97 in pre-market trading after jumping 15% on Friday. XPeng recently reported third-quarter FY22 sales growth of 19.3% year-on-year, to RMB6.82 billion ($0.96 billion).
    • Yatsen Holding Limited (NYSE:YSG) rose 11.8% to $1.42 in pre-market trading. The company recently posted upbeat quarterly results.
    • Niu Technologies (NASDAQ:NIU) rose 11.3% to $4.74 in pre-market trading after gaining over 10% on Friday. Niu Technologies recently reported worse-than-expected Q3 EPS results.
    • Winc, Inc. (NYSE:WBEV) rose 11.1% to $0.23 in pre-market trading after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
    • Qutoutiao Inc. (NASDAQ:QTT) rose 10.8% to $0.7650 in pre-market trading after surging more than 30% on Friday.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 10.4% to $3.68 in pre-market trading after jumping over 14% on Friday. Kingsoft Cloud recently reported a third-quarter FY22 revenue decline of 18.4% year-on-year to $276.8 million, missing the consensus of $313.2 million.
    • HUYA Inc. (NYSE:HUYA) gained 10.2% to $3.23 in pre-market trading after gaining around 10% on Friday
    • The Very Good Food Company Inc. (NASDAQ:VGFC) rose 7.8% to $0.1071 in pre-market trading after dropping 11% on Friday. The Very Good Food Company recently announced new retail distribution with Albertsons.
    • NIO Inc. (NYSE:NIO) rose 7.3% to $14.09 in pre-market trading as China relieved some of its COVID-19 restrictions, easing testing rules in some cities.
    • Li Auto Inc. (NASDAQ:LI) rose 5.8% to $24.09 in pre-market trading as China relieved some of its COVID-19 restrictions, easing testing rules in some cities.
    • Alibaba Group Holding Limited (NYSE:BABA) rose 5.2% to $94.71 in pre-market trading as China relieved some of its COVID-19 restrictions, easing testing rules in some cities.


    Don’t forget to check out our premarket coverage here .


    Losers

    • Top Ships Inc. (NASDAQ:TOPS) fell 62.8% to $1.65 in pre-market trading after the company reported pricing of $13.5 million public offering.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) shares fell 21.5% to $0.27 in pre-market trading after declining around 5% on Friday.
    • Myomo, Inc. (NYSE:MYO) fell 14.1% to $0.5500 in pre-market trading after dipping 13% on Monday. The company, last month, posted upbeat quarterly results.
    • Performance Shipping Inc. (NASDAQ:PSHG) shares fell 13% to $3.75 in pre-market trading after gaining over 5% on Friday.
    • SES AI Corporation (NYSE:SES) fell 7.7% to $4.55 in pre-market trading. SES AI, last month, posted a Q3 loss of $0.08 per share.
    • Nayax Ltd. (NASDAQ:NYAX) shares fell 7.4% to $19.47 in pre-market trading. Jefferies, on Friday, initiated coverage on Nayax with a Hold rating and announced a price target of $22.
    • Yunhong CTI Ltd. (NASDAQ:CTIB) fell 6.8% to $0.52 in pre-market trading after climbing around 47% on Friday.
    Get the next $BABA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BABA
    $BILI
    $CLVS
    $COSM

    CompanyDatePrice TargetRatingAnalyst
    Alibaba Group Holding Limited
    $BABA
    2/18/2026Buy → Hold
    Erste Group
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$200.00 → $180.00Overweight
    Morgan Stanley
    More analyst ratings

    $BABA
    $BILI
    $CLVS
    $COSM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Ye Changqing claimed ownership of 50,000 units of American depositary shares (SEC Form 3)

    3 - Niu Technologies (0001744781) (Issuer)

    3/4/26 8:33:02 AM ET
    $NIU
    Auto Manufacturing
    Industrials

    New insider Cheng Mei Wei claimed ownership of 20,000 units of American depositary shares (SEC Form 3)

    3 - Niu Technologies (0001744781) (Issuer)

    3/4/26 8:33:01 AM ET
    $NIU
    Auto Manufacturing
    Industrials

    New insider Zhang Jinshu claimed ownership of 54,000 units of American depositary shares (SEC Form 3)

    3 - Niu Technologies (0001744781) (Issuer)

    3/4/26 8:30:31 AM ET
    $NIU
    Auto Manufacturing
    Industrials

    $BABA
    $BILI
    $CLVS
    $COSM
    SEC Filings

    View All

    SEC Form 6-K filed by Alibaba Group Holding Limited

    6-K - Alibaba Group Holding Ltd (0001577552) (Filer)

    3/6/26 6:15:10 AM ET
    $BABA
    Real Estate

    SEC Form 6-K filed by Bilibili Inc.

    6-K - Bilibili Inc. (0001723690) (Filer)

    3/6/26 6:05:03 AM ET
    $BILI
    EDP Services
    Technology

    SEC Form 6-K filed by Bilibili Inc.

    6-K - Bilibili Inc. (0001723690) (Filer)

    3/6/26 6:04:09 AM ET
    $BILI
    EDP Services
    Technology

    $BABA
    $BILI
    $CLVS
    $COSM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $BABA
    $BILI
    $CLVS
    $COSM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alibaba downgraded by Erste Group

    Erste Group downgraded Alibaba from Buy to Hold

    2/18/26 9:41:39 AM ET
    $BABA
    Real Estate

    Kingsoft Cloud upgraded by Goldman with a new price target

    Goldman upgraded Kingsoft Cloud from Neutral to Buy and set a new price target of $15.60

    2/11/26 7:42:03 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Li Auto downgraded by Analyst with a new price target

    Analyst downgraded Li Auto from Neutral to Underweight and set a new price target of $14.00

    2/9/26 7:00:29 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $BABA
    $BILI
    $CLVS
    $COSM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BABA
    $BILI
    $CLVS
    $COSM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alibaba Group Will Announce December Quarter 2025 Results on March 19, 2026

    Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba" or "Alibaba Group") today announced that it will report its unaudited financial results for the quarter ended December 31, 2025 before the U.S. market opens on Thursday, March 19, 2026, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Hong Kong Time) the same day. All participants must pre-register to join this conference call using the Participant Registration link below: English: https://s1.c-conf.com/diamondpass/10052713-hndm7s.html Chinese: https://s1.c-conf.com/diamondpass/10052714-wh6tua.html Upon registration, each pa

    3/6/26 4:00:00 AM ET
    $BABA
    Real Estate

    Tuniu Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results and Shareholder Return Plan

    NANJING, China, March 5, 2026 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Highlights for the Fourth Quarter of 2025 Net revenues in the fourth quarter of 2025 increased by 20.3% year-over-year to RMB123.5 million (US$17.7 million[1]).Revenues from package tours in the fourth quarter of 2025 increased by 35.3% year-over-year to RMB102.1 million (US$14.6 million).Net income in the fourth quarter of 2025 was RMB1.5 million (US$0.2 million), compared to a net loss of RMB25.1 million in the fourth quarter

    3/5/26 5:00:00 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    SHANGHAI, March 05, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights: Average daily active users (DAUs) were 113.0 million, an increase of 10% year over year.Average daily time spent per active user were 107 minutes, an increase of 8% year over year.Total net revenues were RMB8.32 billion (US$1,189.9 million), an increase of 8% year over year. Advertising revenues, a key driver of total net revenues, were RMB3.04 billion (US$435.0 milli

    3/5/26 5:00:00 AM ET
    $BILI
    EDP Services
    Technology

    $BABA
    $BILI
    $CLVS
    $COSM
    Financials

    Live finance-specific insights

    View All

    Alibaba Group Will Announce December Quarter 2025 Results on March 19, 2026

    Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba" or "Alibaba Group") today announced that it will report its unaudited financial results for the quarter ended December 31, 2025 before the U.S. market opens on Thursday, March 19, 2026, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Hong Kong Time) the same day. All participants must pre-register to join this conference call using the Participant Registration link below: English: https://s1.c-conf.com/diamondpass/10052713-hndm7s.html Chinese: https://s1.c-conf.com/diamondpass/10052714-wh6tua.html Upon registration, each pa

    3/6/26 4:00:00 AM ET
    $BABA
    Real Estate

    Tuniu Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results and Shareholder Return Plan

    NANJING, China, March 5, 2026 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Highlights for the Fourth Quarter of 2025 Net revenues in the fourth quarter of 2025 increased by 20.3% year-over-year to RMB123.5 million (US$17.7 million[1]).Revenues from package tours in the fourth quarter of 2025 increased by 35.3% year-over-year to RMB102.1 million (US$14.6 million).Net income in the fourth quarter of 2025 was RMB1.5 million (US$0.2 million), compared to a net loss of RMB25.1 million in the fourth quarter

    3/5/26 5:00:00 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    SHANGHAI, March 05, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights: Average daily active users (DAUs) were 113.0 million, an increase of 10% year over year.Average daily time spent per active user were 107 minutes, an increase of 8% year over year.Total net revenues were RMB8.32 billion (US$1,189.9 million), an increase of 8% year over year. Advertising revenues, a key driver of total net revenues, were RMB3.04 billion (US$435.0 milli

    3/5/26 5:00:00 AM ET
    $BILI
    EDP Services
    Technology

    $BABA
    $BILI
    $CLVS
    $COSM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Tuniu Corporation

    SC 13D/A - Tuniu Corp (0001597095) (Subject)

    12/6/24 6:30:27 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by SES AI Corporation

    SC 13D/A - SES AI Corp (0001819142) (Subject)

    11/19/24 4:15:56 PM ET
    $SES
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by HUYA Inc.

    SC 13G/A - HUYA Inc. (0001728190) (Subject)

    11/14/24 7:57:41 PM ET
    $HUYA
    Computer Software: Programming Data Processing
    Technology

    $BABA
    $BILI
    $CLVS
    $COSM
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Zhihu Inc. Announces Resignation of Chief Technology Officer

    BEIJING, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the resignation of Mr. Bin Sun from his position as the Company's chief technology officer due to personal reasons, effective from September 30, 2025. "On behalf of our board and management team, I extend our sincere gratitude to Mr. Sun for his valuable contribution as our chief technology officer," commented Mr. Yuan Zhou, chairman of the board and chief executive officer of the Company. "We wish him all the best in his future endeavors." About Zhihu Inc. Zhihu Inc. (NYSE:ZH, HKEX: 2390)) is a leading online content comm

    9/30/25 6:00:12 AM ET
    $ZH
    Real Estate

    SES AI Appoints Andrew Boyd to Board of Directors

    Investment Community and Capital Markets Veteran Replaces Michael Noonen SES AI Corporation ("SES AI") (NYSE:SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced it has appointed Andrew Boyd to the Board of Directors. He replaces Michael Noonen, who informed the Company of his desire to resign in order to focus on his other professional endeavors. Mr. Boyd currently serves as Partner at Bramalea Partners, LLC, a technology focused fund manager which he founded in January 2020. Prior to Bramalea, Mr. Boyd served in a variety of roles at Fidelity Management & Research Company over a 15-year career, culmin

    9/3/25 7:00:00 AM ET
    $SES
    Industrial Machinery/Components
    Miscellaneous